BIOTON Revenue

BIOTON had revenue of 49.12M PLN in the quarter ending March 31, 2026, a decrease of -25.15%. This brings the company's revenue in the last twelve months to 137.05M, up 14.52% year-over-year. In the year 2025, BIOTON had annual revenue of 282.52M with 35.98% growth.

Revenue (ttm)

137.05M

Revenue Growth

+14.52%

P/S Ratio

1.24

Revenue / Employee

732.84K

Employees

364

Market Cap

330.15M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	282.52M	74.76M	35.98%
Dec 31, 2024	207.76M	26.13M	14.38%
Dec 31, 2023	181.64M	-51.52M	-22.10%
Dec 31, 2022	233.16M	70.13M	43.01%
Dec 31, 2021	163.03M	-58.75M	-26.49%
Dec 31, 2020	221.79M	19.76M	9.78%
Dec 31, 2019	202.03M	-39.13M	-16.23%
Dec 31, 2018	241.17M	-120.48M	-33.31%
Dec 31, 2017	361.65M	13.86M	3.98%
Dec 31, 2016	347.79M	-56.61M	-14.00%
Dec 31, 2015	404.41M	27.11M	7.18%
Dec 31, 2014	377.30M	36.95M	10.85%
Dec 31, 2013	340.36M	-65.95M	-16.23%
Dec 31, 2012	406.30M	117.32M	40.60%
Dec 31, 2011	288.98M	-89.11M	-23.57%
Dec 31, 2010	378.10M	161.25M	74.36%
Dec 31, 2009	216.85M	-76.67M	-26.12%
Dec 31, 2008	293.52M	22.58M	8.33%
Dec 31, 2007	270.94M	55.46M	25.74%
Dec 31, 2006	215.48M	63.89M	42.15%
Dec 31, 2005	151.59M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Ryvu Therapeutics	88.38M
Synthaverse	42.19M
Mabion	17.61M
Molecure	6.52M
Urteste	2.50M
Captor Therapeutics Spolka Akcyjna	2.38M
Pharmena	1.61M
Poltreg	250.00K

Revenue Rankings